SF17 Therapeutics

SF17 Therapeutics is a next-generation precision immunotherapy drug analysis platform that uses artificial intelligence technology to analyze patients' clinical testing data and provides highly targeted autoimmune or tumor immunotherapy solutions based on the patient’s own immune system. The SF17 Therapeutics analysis platform can also be used to discover novel drug combinations.